ADMA — ADMA Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for ADMA Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	55.9	51.1	86.5	51.4	103
Net Total Accounts Receivable
Net Total Receivables	13.2	28.6	15.5	27.4	50
Total Inventory
Prepaid Expenses
Total Current Assets	154	209	270	257	331
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	45.9	58.2	68.7	63.5	63.3
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	208	276	348	329	489
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	19.9	30.4	39.3	49.8	55.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	119	135	196	194	140
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	88.2	141	152	135	349
Total Liabilities & Shareholders' Equity	208	276	348	329	489
Total Common Shares Outstanding